Dear Colleagues and Friends,
Welcome to the IASLC 2026 Hot Topic in Basic and Translational Science Meeting: Resistance to Immunotherapy. We are delighted to welcome you to this focused and highly collaborative gathering of scientists, clinicians, and thought leaders dedicated to addressing one of the most pressing challenges in lung cancer care.
Over the course of this meeting, we will examine the biological mechanisms underlying primary and acquired resistance to immunotherapy, explore tumor–immune interactions and the role of the tumor microenvironment, and discuss emerging biomarkers and novel therapeutic strategies to overcome resistance. Through expert-led
presentations, panel discussions, and interactive sessions, our goal is to bridge cutting-edge discovery with clinical application—accelerating progress toward more durable and effective immunotherapy outcomes for patients.
We look forward to welcoming you to Dublin, Ireland, in June 2026.

Fabrizio Bianchi, PhD
IRCCS Casa Solleivo della Sofferenza Hospital, Italy

Ferdinando Cerciello, PhD
Bern University Hospital

Floris Dammeijer, MD, PhD
Erasmus Medical Center Rotterdam, The Netherlands

Patrick Forde, MD, PhD
Trinity College Dublin, Ireland

Sandra Ortiz-Cuaran, PhD
Cancer Research Center of Lyon | Centre Leon Berard, France
Ming-Sound Tsao, FRCPC, MD | Princess Margaret Cancer Centre
“IASLC Hot Topic meetings
bring together world experts in basic and translational research to discuss cutting-edge science in thoracic malignancies. The presentations and discussions
are truly exciting and inspiring. ”


